When was Functional Fluidics founded?

Functional Fluidics was founded in 2013 and raised its 1st funding round 6 years after it was founded.

Where is Functional Fluidics located?

Functional Fluidics is headquartered in Detroit, United States.

Who is the current CEO of Functional Fluidics?

Patrick Hines of Functional Fluidics.

How many employees does Functional Fluidics have?

As of Aug 31, 2026, the latest employee count at Functional Fluidics is 18.

Is Functional Fluidics a funded company?

Functional Fluidics is a funded company, having raised a total of $3.58M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 01, 2019.

When was the latest funding round of Functional Fluidics?

Functional Fluidics' latest funding was a $***** Grant (prize money) round on Sep 20, 2024, with participation from 1 investor.

Where does Functional Fluidics rank among its competitors?

Functional Fluidics ranks 3rd amongst 18 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Quiver Bioscience, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of Functional Fluidics?

Functional Fluidics' top competitors include Quiver Bioscience, Forcyte Biotechnologies and MaxWell Biosystems. Among them, Quiver Bioscience secured the most recent funding round in April, 2026.

Functional Fluidics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of microfluidics-based assays to study blood disorders. The company uses microfluidic channels coated with various types of substrates and markers to simulate blood flow in vivo and then utilize high-end analytical methods to study the behavior of the cells under various controlled conditions. The assay paradigms include flow adhesion, whole blood thrombosis assays, flow adhesion dynamics, a reversal of flow adhesion, etc. The company currently offers its expertise to clients for drug discovery and companion diagnostics development for blood disorders such as sickle cell disease, and a wide range of clotting and bleeding defects.

Website: www.functionalfluidics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

Detroit, United States

Stage

Series A

Total Funding

$3.58M in 6 rounds

Latest Funding Round

Grant (prize money), Sep 20, 2024, $*****

Investors

NYBC Ventures & 9 more

Ranked

3^rd among 18 active competitors

Employee Count

18 as on Aug 31, 2026

Similar Companies

Quiver Bioscience & 20 more

View Functional Fluidics' full profile

Functional Fluidics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Functional Fluidics Inc. CIN: 851002822 , United States, Active	Jan 27, 2021	-	-	-

Functional Fluidics has raised a total funding of $3.58M over 6 rounds. Its first funding round was on Mar 01, 2019. Its latest funding round was a Grant (prize money) round on Sep 20, 2024 for $*****. 1 investor participated in its latest round. Functional Fluidics has 10 institutional investors.

Here is the list of recent funding rounds of Functional Fluidics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 20, 2024	8326299	Grant (prize money)	7369294	6270065	9933759	2689908
Dec 07, 2023	1091374	Series A	7816090	5282634	8761453	6124833
Jan 05, 2021	5550356	Series A	6959278	5540020	3819174	8745801

Access funding benchmarks and valuations. Sign up today!

View details of Functional Fluidics's funding rounds and investors

The founders of Functional Fluidics is Patrick Hines.

Here are the details of Functional Fluidics' key team members:

Patrick Hines: Founder & CEO of Functional Fluidics.
Contact Info: 1 email address

View details of Functional Fluidics's Founder profiles and Board Members

Functional Fluidics' employee count trend

Functional Fluidics has 18 employees as of Aug 26. Here is Functional Fluidics's employee count trend over the years:

Employee count trend for Functional Fluidics

Uncover Functional Fluidics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Functional Fluidics include Quiver Bioscience, Forcyte Biotechnologies and MaxWell Biosystems. Here is the list of Top 10 competitors of Functional Fluidics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Quiver Bioscience 2013, Cambridge (United States), Acquired	Developer of transformational medicines for neurological disorders	-	NIH, HHS	53/100
2nd	Forcyte Biotechnologies 2017, Los Angeles (United States), Seed	Developer of automated single-cell contractility screening system for drug discovery	$5.7M	Y Combinator, Acequia Capital & 4 others	44/100
3rd	Functional Fluidics 2013, Detroit (United States), Series A	Developer of microfluidics-based assays to study blood disorders	$3.58M	Wavemaker 360, ID Ventures & 8 others	40/100
4th	MaxWell Biosystems 2016, Basel (Switzerland), Series A	Developer of an in vitro assay platform based on electrophysiology	$4.64M	Venture Kick, Sensirion & 3 others	40/100
5th	Novoheart 2014, Vancouver (Canada), Acquired	Tissue engineering tools for developing bioartificial heart	-	ITC	39/100
6th	CellsBin 2022, New Haven (United States), Funding Raised	Developer of nanophotonic platforms for detecting and isolating rare cells	-	Connecticut Innovations	32/100
7th	Multi Channel Systems 1996, Reutlingen (Germany), Acquired	Tools for Electrophysiology	-	Europa	32/100
8th	Cellular Analytics 2019, Toronto (Canada), Unfunded	Developer of microfluidic platform for cell analytics	-	-	32/100
9th	Cambridge NeuroTech 2013, Cambridge (United Kingdom), Unfunded	Provider of electrophysiology-based solutions	-	-	31/100
10th	Modular Bionics 2011, Santa Ana (United States), Funding Raised	Neurotechnology company enabling innovative nervous system experiments with microelectrodes and wireless devices	-	HHS	29/100